News
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may be associated…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…
FDA approves Boostrix for older people
The U.S. Food and Drug Administration (FDA) has approved the Boostrix vaccine to prevent tetanus, diphtheria, and pertussis in people 65 years and older.…
FDA warns of risk of surgical mesh used to repair pelvic organ prolapse
The U.S. Food and Drug Administration has issued a warning for surgical placement of mesh through the vagina to repair pelvic organ transplant. Adverse…
FDA warns against Evital
The U.S. Food and Drug Administration (FDA) is warning consumers not to take the emergency birth control medicine labeled as Evital, which may not…
Environment, health, & safety
With the growing reuse of single-use medical devices, ANA supports improvements in end-of-use product management and research on ethical and safety issues related to…
FDA updates safety data for silicone gel-filled breast implants
A new report of data from studies conducted by manufacturers confirms that silicone gel-filled breast implants are “safe and effective when used as intended.”…
FDA proposes new policy for some devices
The U.S. Food and Drug Administration (FDA) has proposed a new policy that reduces premarket notification requirements related to devices that have had their…
FDA changes sunscreen labeling requirements
The U.S. Food and Drug Administration (FDA) has revised requirements for sunscreen labeling. The final rule takes effect by summer 2012. Read more.
FDA releases draft guideline related to nanotechnology
The Food and Drug Administration (FDA) has released “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” a draft guidance document available for…
FDA approves Nulojix for prevention of acute rejection in kidney transplant patients
The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had a kidney…
FDA approves first ceramic-on-metal total hip replacement system
The U.S. Food and Drug Administration (FDA) has approved the Pinnacle CoMplete Acetabular Hip System, the first ceramic-on-metal total hip replacement system for patients…
FDA podcast addresses dangers of long-term, high dosage use of Diflucan during pregnancy
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…
FDA approves Boostrix for older people
The U.S. Food and Drug Administration (FDA) has approved the Boostrix vaccine to prevent tetanus, diphtheria, and pertussis in people 65 years…
FDA warns of risk of surgical mesh used to repair pelvic organ prolapse
The U.S. Food and Drug Administration has issued a warning for surgical placement of mesh through the vagina to repair pelvic organ…
FDA warns against Evital
The U.S. Food and Drug Administration (FDA) is warning consumers not to take the emergency birth control medicine labeled as Evital, which…
Environment, health, & safety
With the growing reuse of single-use medical devices, ANA supports improvements in end-of-use product management and research on ethical and safety issues…
FDA updates safety data for silicone gel-filled breast implants
A new report of data from studies conducted by manufacturers confirms that silicone gel-filled breast implants are “safe and effective when used…
FDA proposes new policy for some devices
The U.S. Food and Drug Administration (FDA) has proposed a new policy that reduces premarket notification requirements related to devices that have…
FDA changes sunscreen labeling requirements
The U.S. Food and Drug Administration (FDA) has revised requirements for sunscreen labeling. The final rule takes effect by summer 2012. Read…
FDA releases draft guideline related to nanotechnology
The Food and Drug Administration (FDA) has released “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” a draft guidance document…
FDA approves Nulojix for prevention of acute rejection in kidney transplant patients
The U.S. Food and Drug Administration (FDA) has approved Nulojix (belatacept) for prevention of acute rejection in adult patients who have had…
FDA approves first ceramic-on-metal total hip replacement system
The U.S. Food and Drug Administration (FDA) has approved the Pinnacle CoMplete Acetabular Hip System, the first ceramic-on-metal total hip replacement system…
Poll




NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

